Recently added
This page was added on 14 November 2024.
Updates made
This page was updated on [date-counter-updated-date]. View history of updates
Registered for use in people aged 5 years to <12 years
COVID-19 vaccine containing nucleoside-modified mRNA encoding the spike glycoproteins of SARS-CoV-2 JN.1 strain.
Single dose vial without preservative containing 0.3 mL of concentrated suspension for injection vaccine. Requires no dilution. Each vial contains 1 dose in 0.48mL.
Each 0.3 mL dose contains:
- 10 µg mRNA encoding the SARS-CoV-2 JN.1 spike glycoprotein
- ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate) (ALC-0315)
- 2-[(polyethylene glycol)-2000]-N,N-ditetradecylacetamide (ALC-0159)
- Distearoylphosphatidylcholine (DSPC)
- Cholesterol
- Trometamol
- Trometamol hydrochloride
- Sucrose
- Water for injections
For Product Information and Consumer Medicine Information about Comirnaty JN.1 visit the Therapeutic Goods Administration website.
Additional vaccine information
For detailed advice on vaccine dosage, administration, contraindications and precautions, and variations from product information, please visit the relevant disease chapter/s.